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Abstract 
BACKGROUND AND AIM: Head and neck cancer is one of the six most prevalent neoplasms worldwide. Regardless of 
tumor site, deterioration of basic functions affecting head and neck areas are perceived and affect patients' lives. The 
aim of this study was to evaluate quality of life (Short Form) and oral health related quality of life (OHIP-14) in patients 
with head and neck cancer. 
METHODS: This study was conducted on 42 patients being treated for head and neck cancer. Data collected from the 
survey included demographic (sex, age, and educational level), quality of life (QoL), and Oral Health Related Quality of 
Life (OHRQoL), which were, respectively, measured by short form-36 and OHIP-14 questionnaire. Cancer 
measurements were collected from the patient’s hospital records. ANOVA and t-tests were used to determine the 
association between QoL scores and the variables. 
RESULTS: 83.3% of the participants were men and 16.7% were women. Their mean age was 59.39 ± 12.5 years. 33.3% 
of the participants had oral cancer. 54.8% of patients had stage III cancer. The mean score of OHIP-14 was  
21.4 ± 10.11. There was a significant correlation between OHIP-14 and site of cancer, and dose of radiation (P = 0.020 
and P = 0.009, respectively). The best score of SF-36 was in social function (55.11 ± 30.9) and the worst score of SF-36 
was in vitality domain (29.76 ± 9.67). There was a significant correlation between physical function, vitality and social 
activity with OHIP-14 (P = 0.020, P = 0.011, P = 0.009, respectively). 
CONCLUSIONS: The QoL scores in Kerman like the other studies were low. Head and neck cancer can have a negative 
impact on QoL. Further research is recommended. 
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ral cancer is the sixth most common 
neoplasm in the world; approximately 
900000 cases of this disease are 
identified every year.1 Epidemiologic 
studies show an increase in oral cancer 
incidence in the general population and 
among young people.2 Despite the 
progression in treatment 5-years survival rate 
is between 50-60%.2-5 Oral health related 
quality of life is the self-evaluation of 
functional, psychological, sociological 
conditions that are affected by oral health 
condition.6 One of the most important effects 
of treatment is quality of life improvement.2 
Ogama et al. showed radiation causes 
xerostomia and mucositis that can reduce the 
quality of life of patients.7 Hanna et al. 
evaluated the quality of life of patients who 
had larynx carcinoma and were treated in 
different ways. They showed that the patients 
treated by surgery and radiotherapy had 
more problems in social functioning than the 
chemoradiation group Patients treated by 
surgery had a significantly higher number of 
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sensorial complications, and a higher number 
of xerostomia was reported in those treated 
by chemotherapy.8  
Andrade et al. showed that patients with 
larger tumors and tumors in the posterior of 
the mouth had significantly lower quality of 
life and their chewing ability was limited.9 
Mochizuki et al. showed that 
psychological status and quality of life were 
reduced in patients with oral cancer.10 Kakoei 
et al. showed xerostomia, due to 
radiotherapy, plays an important role in 
worsening QoL among patients who undergo 
radiotherapy for head and neck cancer.11 
Since similar research has not been done in 
Iran, this study planned to assess oral health 
related quality of life (OHRQoL) and quality 
of life (SF-36) in oral cancer patients referred 
to the Oncology Center at the University of 
Medical Sciences, Kerman, Iran, which is in 
fact the only oncology center in the Kerman 
province. 
Methods 
This descriptive cross-sectional study was 
conducted on 42 patients with head and neck 
cancer referred to the Oncology Center of 
Kerman University of Medical Sciences 
(Shafa Hospital). The participants were 
selected with simple sampling method. The 
aim of this project was explained to patients 
and then after obtaining written consents 
from them, they were enrolled into the study. 
Data collection was obtained from 
questionnaires consisting of 3 parts. The first 
part consisted of demographic characteristics 
and cancer information including histological 
type, location, clinical staging, method of 
treatment, and dose of radiation. The second 
part was the Persian version of the Oral 
Health Impact Profile-14 (OHIP-14) 
questionnaire. Validity and reliability of this 
questionnaire were assessed by Mirzadeh.12 
OHIP-14 consist of 14 questions about 
patients’ problems due to their teeth or 
dentures. Answers were measured by Likert 
scale (never (0), seldom (1), occasionally (2), 
always (3), and every time (4)), so the rate of 
numbers are between 0-56. Part 3 was the 
Persian version of the quality of life (SF-36) 
questionnaire that consists of 8 domains of 
general health, the role of physical 
limitations, vitality, pain, social functioning, 
general mental health, and the role emotional 
limitations. Answers were measured from 0-
100 in each domain, higher marks mean 
better quality of life. Reliability of this 
questionnaire was 85% based on alfa 
chronbach.13 Validity and reliability of this 
questionnaire were assessed by Montazeri et 
al.14 Four weeks after completion of 
radiotherapy and radiotherapy-induced 
improvement of acute symptoms, the 
patients were questioned. In order to 
complete the questionnaire, personal 
information was completed by the patient 
and disease characteristics, including 
location, type and tumor staging was 
extracted from patients’ records and 
treatment records by the radiotherapist. 
In cases where the patient was low-literate 
or illiterate questions were read for the 
patient by the researcher who tried to read all 
questions in an identical manner in order to 
prevent any prejudice or from guiding the 
patient to give a specific answer. After 
collecting the data, they were entered into the 
computer by using SPSS software version 16 
and analyzed by t-test, ANOVA and LSD 
tests. The proposal of this study was 
approved under the ethical code K/89/37 by 
Kerman University of Medical Sciences. 
Results 
In this study, 42 patients were examined; 35 
men (83.3%) and 7 women (16.7%). Their mean 
age was 56.39   ± 12.15 years. 52.4% had diploma 
and lower education. Radiotherapy dose in 
66.6% was 70 GY. 40.5% had larynx cancer, and 
33.3% had mouth cancer, and 54.8% of the 
cases had stage III cancer (Table1). 
The mean and standard deviation score of 
oral health-related quality of life was  
21.4 ± 10.11, with minimum 3 and maximum 
41 points. The most important problem was 
changes in the patients’ sense of taste. 
Oral health-related quality of life index 
score based on individual characteristics and 
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Table 1. Demographic variables and OHIP-14 
Variables mean ±  SD (OHIP-14) Number (%) Test result (P value) 
Sex Male 20.57 (9.98) 35 (83.3) NS* Female 25.71 (10.45) 7 (16.7) 
Education level 
Illiterate 21.25 (10.16) 12 (28.6) 
NS Diploma and below 22.00 (10.07) 22 (52.4) 
University 21.43 (11.39) 8 (19.0) 
Tumor site 
Nasopharynx 10.00 (4.24) 4 (9.5) 
P < 0.050 Larynx 22.35 (9.53) 17 (40.5) Mouth 26.14 (6.92) 14 (33.3) 
Neck 21.43 (13.11) 7 (16.7) 
Clinical stage 
 16.00 (0.00) 1 (2.4) 
NS  20.36 (10.15) 11 (26.2)  22.52 (10.27) 23 (54.8) 
V 20.29 (11.28) 7 (16.7) 
Treatment dose 
60 29.56 (7.78) 9 (21.4) 
P < 0.050 66 16.00 (9.19) 5 (11.9) 
70 19.79 (9.73) 28 (66.6) 
* Not Significant 
 
type of disease were compared and results in 
tumor site and dose of therapy showed a 
significant difference. 
Additional tests showed quality of life of 
patients with nasopharyngeal tumors was 
higher in comparison with patients who 
had tumor in the larynx and mouth  
(P < 0.050), but it was similar to patients 
with cervical masses. 
The patients who were irradiated with 60 
Gy had the lowest quality of life (P < 0.050). 
Calculated scores for quality of life domains  
based on the questionnaire SF-36 showed that 
the highest quality of life was in social 
functioning and physical functioning and the 
lowest was in vitality (Figure 1). 
Discussion 
In this study, the mean of OHIP-14 was  
21.4 ± 10.11. McMillan showed that the mean 
score of OHIP-14 was higher for patients with 
newly diagnosed nasopharyngeal carcinoma 
in comparison to those who had finished 
their radiotherapy treatment.15 
 
 
Figure 1. Mean of QoL in different domains of SF-36 
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In this study the relationship between 
OHRQoL and the location and staging of 
tumors was statistically significant. Average 
score of those who had oral tumors was 
lower than other people. The most important 
problem, which was change in their sense of 
taste, can be related to the decrease in saliva. 
Alicikus et al., in a cross-sectional study 
of QOL in patients with head and neck 
cancer who had radiotherapy with or 
without chemotherapy, demonstrated that 
the tumor site and its clinical staging was 
significantly associated with patients' 
quality of life.16 Fang et al. showed that 
patients who had tumor in stage 4 QoL had 
lower quality of life than patients in stage 
1,2 and 3 QoL, and this is consistent with the 
results of the present study.17 
In this study, the mean OHRQoL score was 
20.57 ± 9.97 in men and 26.5 ± 11.22 in women. 
T-test showed no significant association 
between sex and OHRQoL. Caglayan et al. 
showed no statistical relationship between sex 
and OHIP-14, which is in agreement with the 
results of our study.18 
The results of this study showed the 
lowest score of SF was in vitality (29.76 from 
100), this is incompatible with the results of 
the study by Herce et al. (2009).19 This 
difference can be explained by the social and 
cultural differences of the two studies. 
Fang et al. showed that the average score 
of the 8 domains of SF-36 was significantly 
lower in patients with oral cancer than other 
patients.17 Herce et al. (2009) showed that 
patients with oral cancer had lower social 
activity and higher level of pain than the 
control group.19 
Although Hanna et al. showed that there 
was no difference in SF-36 of patients treated 
by total laryngectomy, and those with 
chemoradiation. Patients treated with 
chemoradiotherapy had fewer problems in 
social functioning than those treated by 
surgery or radiotherapy.8 
Herce et al. (2007) showed no difference 
between quality of life of patients with oral 
cancer and ordinary people. However, they 
showed a small difference in social 
functioning and emotional domains of 
patients with oral cancer and ordinary 
people.20 Karvonen et al. showed that the 
physical aspect of SF-36 was associated with 
the survival rate of patients with head and 
neck cancer.21 It seems that the concept of 
quality of life varies due to differences in 
lifestyle and expectations of patients in 
different cultures. 
In the present study, the OHIP-14 was 
correlated with the dose of treatment. Pow et 
al. (2006) also showed that patients with 
nasopharyngeal carcinoma and undergoing 
Intensity-Modulated Radiotherapy (IMRT) 
had higher quality of life than those treated 
with conventional radiation.22 Kakoei et al. 
reported that decrease in flow of saliva in 
patient who undergo radiotherapy causes a 
decrease in QoL.11 Kanatas et al. argue that 
the quality of life questionnaire should be 
used as an additional tool for giving 
information to patients, identifying their 
problems, and giving them the opportunity 
to solve their problem under the supervision 
of a specialist.23 
Conclusion 
Quality of life in patients with head and neck 
cancer in Kerman, like the other studies, is 
low. Quality of life can be a valuable tool for 
screening and identifying patients with low 
quality of life. This identified group must be 
followed in order to detect early recurrence of 
disease and use appropriate treatment for 
improving their survival rate. We also suggest 
that patients who are treated for head and 
neck cancer be trained by nurses and social 
workers to improve their life quality. 
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